Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 740

1.

Regression analysis in an illness-death model with interval-censored data: A pseudo-value approach.

Sabathé C, Andersen PK, Helmer C, Gerds TA, Jacqmin-Gadda H, Joly P.

Stat Methods Med Res. 2019 Apr 16:962280219842271. doi: 10.1177/0962280219842271. [Epub ahead of print]

PMID:
30991888
2.

[Tacrolimus ointment in the management of atopic keratoconjunctivitis].

Benaim D, Tétart F, Bauvin O, Delcampe A, Joly P, Muraine M, Gueudry J.

J Fr Ophtalmol. 2019 Mar 29. pii: S0181-5512(19)30075-0. doi: 10.1016/j.jfo.2018.07.018. [Epub ahead of print] French.

PMID:
30935698
3.

[Update of the French recommendations for the management of pemphigus].

Jelti L, Prost-Squarcioni C, Ingen-Housz-Oro S, Caux F, Bernard P, Bedane C, Alexandre M, Dereure O, Quereux G, Le Bidre E, Plée J, Picard-Dahan C, Le Roux-Villet C, Duvert-Lehembre S, Richard MA, Delaporte E, Debarbieux S, Jullien D, D'Incan M, Konstantinou MP, Bouaziz JD, Tancrède-Bohin E, Doutre MS, Bourgault Villada I, Cordel N, Sassolas B, Viguier MA, Mellottée B, Jouen F, Hebert V, Joly P; Centre de référence des maladies bulleuses auto-immunes (MALIBUL); Groupe Bulles de la SFD et la Filière des maladies rares dermatologiques (FIMARAD).

Ann Dermatol Venereol. 2019 Apr;146(4):279-286. doi: 10.1016/j.annder.2019.01.018. Epub 2019 Mar 29. French. No abstract available.

PMID:
30929874
4.

[The place of Androcur® in the treatment of diffuse female pattern hair loss].

Pham AD, Guillot B, Beylot-Barry M, Chosidow O, Reygagne P, Joly P.

Ann Dermatol Venereol. 2019 Apr;146(4):311-312. doi: 10.1016/j.annder.2019.02.008. Epub 2019 Mar 27. French. No abstract available.

PMID:
30926139
5.

The IgG2 isotype of anti-transcription intermediary factor 1-gamma autoantibodies is a biomarker of mortality in adult dermatomyositis.

Aussy A, Fréret M, Gallay L, Bessis D, Vincent T, Jullien D, Drouot L, Fabienne J, Joly P, Isabelle M, Meyer A, Sibilia J, Bader-Meunier B, Hachulla E, Hamidou M, Huë S, Charuel JL, Fabien N, Viailly PJ, Allenbach Y, Benveniste O, Cordel N, Boyer O; OncoMyositis study group.

Arthritis Rheumatol. 2019 Mar 21. doi: 10.1002/art.40895. [Epub ahead of print]

PMID:
30896088
6.

Tacrolimus ointment in the management of atopic keratoconjunctivitis.

Benaim D, Tétart F, Bauvin O, Delcampe A, Joly P, Muraine M, Gueudry J.

J Fr Ophtalmol. 2019 Apr;42(4):e147-e151. doi: 10.1016/j.jfo.2019.02.003. Epub 2019 Mar 7.

PMID:
30851973
7.

Public perception of dermatologists in France: results from a population-based national survey.

Richard MA, Joly P, Roy Geffroy B, Taïeb C.

J Eur Acad Dermatol Venereol. 2019 Mar 5. doi: 10.1111/jdv.15541. [Epub ahead of print]

PMID:
30835850
8.

Efficacy and safety of oral alitretinoin as treatment for chronic hand eczema in France: a real-life open-label study.

Halioua B, Paul C, Berbis P, Cambazard F, Doutre MS, Joly P, Richard MA, Aubin C, Gruber A, Chosidow O.

Eur J Dermatol. 2019 Feb 1;29(1):59-66. doi: 10.1684/ejd.2018.3484.

PMID:
30827949
9.

Evaluation of agreement between hemoglobin A1c, fasting glucose, and fructosamine in Senegalese individuals with and without sickle-cell trait.

Skinner S, Diaw M, Ndour Mbaye M, Joly P, Renoux C, Masson C, Cuerq C, Lopez P, Ndour M, Diedhiou D, Sow D, Diop S, Samb A, Pialoux V, Connes P.

PLoS One. 2019 Feb 15;14(2):e0212552. doi: 10.1371/journal.pone.0212552. eCollection 2019.

10.

Automatic depletion with Spectra Optia allows a safe 16% reduction of red blood cell pack consumption in exchanged sickle cell anemia patients.

Hequet O, Poutrel S, Connes P, Revesz D, Chelghoum Y, Kebaili K, Cannas G, Gauthier A, Guironnet-Paquet A, Vocanson M, Nicolas JF, Renoux C, Raba M, Cognasse F, Bertrand Y, Hot A, Joly P.

Transfusion. 2019 Feb 12. doi: 10.1111/trf.15188. [Epub ahead of print]

PMID:
30747440
11.

An Additional Case of Hb Saint Nazaire [β103(G5)Phe→Ile; HBB: c.310T>A] Leading to Moderate Erythrocytosis in a French Family.

Bobée V, Feugray G, Brunel V, Joly P, Lahary A.

Hemoglobin. 2019 Jan 30:1-2. doi: 10.1080/03630269.2019.1567529. [Epub ahead of print]

PMID:
30700173
12.

Erratum. Increased Prevalence of Type 2 Diabetes-Related Complications in Combined Type 2 Diabetes and Sickle Cell Trait. Diabetes Care 2018;41:2595-2602.

Skinner SC, Diaw M, Pialoux V, Mbaye MN, Mury P, Lopez P, Bousquet D, Gueye F, Diedhiou D, Joly P, Renoux C, Sow D, Diop S, Ranque B, Vinet A, Samb A, Guillot N, Connes P.

Diabetes Care. 2019 Mar;42(3):494. doi: 10.2337/dc19-er03b. Epub 2019 Jan 23. No abstract available.

13.

Linear IgA bullous dermatosis treated with rituximab.

Pinard C, Hebert V, Lecuyer M, Sacre L, Joly P.

JAAD Case Rep. 2019 Jan 12;5(2):124-126. doi: 10.1016/j.jdcr.2018.11.004. eCollection 2019 Feb. No abstract available.

14.

Secular trends of mortality and dementia-free life expectancy over a 10-year period in France.

Grasset L, Pérès K, Joly P, Sabathé C, Foubert-Samier A, Dartigues JF, Helmer C.

Eur J Epidemiol. 2019 Feb;34(2):115-123. doi: 10.1007/s10654-019-00482-w. Epub 2019 Jan 16.

PMID:
30649704
15.

Efficacy of Immunotherapy in Patients with Metastatic Mucosal or Uveal Melanoma.

Mignard C, Deschamps Huvier A, Gillibert A, Duval Modeste AB, Dutriaux C, Khammari A, Avril MF, Kramkimel N, Mortier L, Marcant P, Lesimple T, Gaudy-Marqueste C, Lesage C, Machet L, Aubin F, Meyer N, Beneton N, Jeudy G, Montaudié H, Arnault JP, Visseaux L, Trabelsi S, Amini-Adle M, Maubec E, Le Corre Y, Lipsker D, Wierzbicka-Hainaut E, Litrowski N, Stefan A, Brunet-Possenti F, Leccia MT, Joly P.

J Oncol. 2018 Dec 2;2018:1908065. doi: 10.1155/2018/1908065. eCollection 2018.

16.

Assessment of liver fibrosis by transient elastography (Fibroscan®) in patients with A1AT deficiency.

Guillaud O, Dumortier J, Traclet J, Restier L, Joly P, Chapuis-Cellier C, Lachaux A, Mornex JF.

Clin Res Hepatol Gastroenterol. 2019 Feb;43(1):77-81. doi: 10.1016/j.clinre.2018.08.016. Epub 2019 Jan 3.

PMID:
30612958
17.

Drepa-Opia: A Pilot Study to Determine the Predictive Factors of Morphine Use and Consumption in Hospitalized Adult Patients with Sickle Cell Disease.

Sabrie M, Cannas G, Tazarourte K, Poutrel S, Connes P, Hot A, Renoux C, Fattoum J, Joly P.

Hemoglobin. 2018 Jul;42(4):217-224. doi: 10.1080/03630269.2018.1529602. Epub 2019 Jan 3.

PMID:
30604640
18.

Liver disease related to alpha1-antitrypsin deficiency in French children: The DEFI-ALPHA cohort.

Ruiz M, Lacaille F, Berthiller J, Joly P, Dumortier J, Aumar M, Bridoux-Henno L, Jacquemin E, Lamireau T, Broué P, Rivet C, Belmalih A, Restier L, Chapuis-Cellier C, Bouchecareilh M, Lachaux A; Groupe Francophone d’Hépatologie Gastroentérologie et Nutrition Pédiatriques.

Liver Int. 2018 Dec 27. doi: 10.1111/liv.14035. [Epub ahead of print]

PMID:
30589493
19.

Higher Frequency of Dipeptidyl Peptidase-4 Inhibitor Intake in Bullous Pemphigoid Patients than in the French General Population.

Plaquevent M, Tétart F, Fardet L, Ingen-Housz-Oro S, Valeyrie-Allanore L, Bernard P, Hebert V, Roussel A, Avenel-Audran M, Chaby G, D'Incan M, Ferrier-Le-Bouedec MC, Duvert-Lehembre S, Picard-Dahan C, Jeudy G, Collet E, Labeille B, Morice C, Richard MA, Bourgault-Villada I, Litrowski N, Bara C, Mahe E, Prost-Squarcioni C, Alexandre M, Quereux G, Bernier C, Soria A, Thomas-Beaulieu D, Pauwels C, Dereure O, Benichou J, Joly P; French Investigators for Skin Adverse Reaction to Drugs; French Study Group on Autoimmune Bullous Skin Diseases.

J Invest Dermatol. 2019 Apr;139(4):835-841. doi: 10.1016/j.jid.2018.10.045. Epub 2018 Dec 10.

PMID:
30543900
20.

Bullous pemphigoid, a dermatosis of the elderly

Hébert V, Joly P.

Rev Prat. 2017 Dec;67(10):1080-1083. French.

PMID:
30512605

Supplemental Content

Loading ...
Support Center